  Cancer cells can acquire a spectrum of stable hybrid epithelial/mesenchymal
(E/M) states during epithelial-mesenchymal transition (EMT). Cells in these
hybrid E/M phenotypes often combine epithelial and mesenchymal features and
tend to migrate collectively commonly as small clusters. Such collectively
migrating cancer cells play a pivotal role in seeding metastases and their
presence in cancer patients indicates an adverse prognostic factor. Moreover,
cancer cells in hybrid E/M phenotypes tend to be more associated with stemness
which endows them with tumor-initiation ability and therapy resistance. Most
recently, cells undergoing EMT have been shown to promote immune suppression
for better survival. A systematic understanding of the emergence of hybrid E/M
phenotypes and the connection of EMT with stemness and immune suppression would
contribute to more effective therapeutic strategies. In this review, we first
discuss recent efforts combining theoretical and experimental approaches to
elucidate mechanisms underlying EMT multi-stability (i.e. the existence of
multiple stable phenotypes during EMT) and the properties of hybrid E/M
phenotypes. Following we discuss non-cell-autonomous regulation of EMT by cell
cooperation and extracellular matrix. Afterwards, we discuss various metrics
that can be used to quantify EMT spectrum. We further describe possible
mechanisms underlying the formation of clusters of circulating tumor cells.
Last but not least, we summarize recent systems biology analysis of the role of
EMT in the acquisition of stemness and immune suppression.
